breast cancer Flashcards
(26 cards)
risk factors
female inc oestrogen exposure - early menarche, late menopause more glandular breast tissue obesity smoking FHx
risk - COCP
small increase risk, but risk returns to normal 10yrs after stopping pill
risk - HRT
increases risk, esp combined HRT
BRCA1
chr17
70% breast cancer by 80yrs
50% ovarian cancer
risk prostate + bowel cancer
BRCA2
chr13
60% breast cancer by 80yrs
20% ovarian cancer
ductal carcinoma in situ (DCIS)
pre-ca/cancerous epithelial cells of breast ducts
potential to become invasive breast cancer (30%)
good prognosis if full excised + adjuvant Rx used
Lobular carcinoma in situ (LCIS )
pre-ca condition, premenopausal women
asymtomatic + undetectable on mammogram
usually picked up on biopsy
Mx with close monitoring
risk invasive cancer in future
Invasive ductal carcinoma (NST)
originate in cells from breast ducts
represents 80% breast cancers
can be seen on mammograms
invasive lobular carcinoma (ILC)
10% of breast cancers
originate breast lobules
not always visible on mammogram
Inflammatory Breast Cancer
present similar to breast abscess/mastitis
worse prognosis
Paget’s Disease of the Nipple
erythematous scaly rash of nipple/areola
indicates breast cancer involving nipple
Breast cancer screening
mammogram every 3yrs to women aged 50-70yrs
high risk patients
- first-degree relative with breast cancer <40 yrs
- first-degree male relative with breast cancer
- first-degree relative with bilateral breast cancer, first diagnosed <50yrs
- 2 first-degree relatives with breast cancer
monitoring of high risk women
annual mammogram
chemoprevention
risk reducing mastectomy/oopherectomy
clinical features
lump: hard, irregular, painless, fixed, tethered
nipple retraction
skin dimpling, oedema
lymphadenopathy
referring - 2wk wait if
unexplained breast lump ≥30yrs
unilateral nipple changes ≥50yrs
consider if
- lump in axilla ≥30yrs
- skin changes suggestive breast cancer
referring - not-urgent referral for
unexplained breast lumps in patients <30yrs
triple diagnostic assessment
clinical assessment - Hx and exam
imaging - USS or mammography
biopsy - fine needle aspiration or core biopsy
imaging - younger women
USS - as they have more glandular breast tissue
helpful to distinguish solid lumps from cystic
imaging - older women
mammorgrams
Ix - when to use MRI
screening in women at high risk
to further assess size and features
Lymph node assessment
USS axilla
USS guided biopsy
sentinel lymph node biopsy
breast cancer receptors
receptors can be tagted by treatments
1/oestrogen receptors
2/progesterone receptors
3/human epidermal growth factor (HER2)
triple negative
breast cancer cells do not express any of the 3 receptors
worse prognosis and treatment options are limited